Renjie Gao
Overview
Explore the profile of Renjie Gao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Feng Y, Cao H, Zhao W, Chen L, Wang D, Gao R
J Cancer
. 2023 Jan;
13(15):3652-3659.
PMID: 36606191
miR-143 is known to be downregulated in various cancer cells and tumors and generally plays a tumor-suppressor role. miR-143. However, the role of miR-143 in the mediation of the sensitivity...
12.
Feng Y, Cao H, Song Z, Chen L, Wang D, Gao R
Aging (Albany NY)
. 2022 Dec;
14(24):9942-9950.
PMID: 36541904
Abiraterone acetate has exhibited impressive results in improving progression-free survival of patients with metastatic castration-resistant prostate cancer. However, many patients may develop abiraterone resistance with a variable duration of response....
13.
Cao H, Wang D, Gao R, Li C, Feng Y, Chen L
PeerJ
. 2022 Jul;
10:e13481.
PMID: 35782093
QiLing decoction (QLD) is a traditional Chinese medicine compound. This study aims to explore the therapeutic effect of QLD in castration-resistant prostate cancer (CRPC) and its potential bio-targets. A total...
14.
Cao H, Wang D, Gao R, Feng Y, Chen L
Aging (Albany NY)
. 2022 Feb;
14(4):1812-1821.
PMID: 35193986
Tumor-associated macrophages (TAMs) are critical immune cells infiltrated into tumor. In present study, we evaluated the effects of Qi Ling (QL), a traditional Chinese medicine on paclitaxel resistance in prostate...
15.
Cao H, Wang D, Sun P, Chen L, Feng Y, Gao R
Am J Cancer Res
. 2021 Dec;
11(11):5715-5725.
PMID: 34873489
To identify novel biomarker(s) in prostate cancer and demonstrate the mechanistic involvements in this disease, RNA-seq was employed to reveal the differentially expressed genes in the blood samples from prostate...
16.
Cao H, Wang D, Sun P, Chen L, Feng Y, Gao R
Aging (Albany NY)
. 2021 Oct;
13(19):23096-23107.
PMID: 34613933
Docetaxel resistance developed in half of castration-resistant prostate cancer (CRPC) patients hinders its long-term clinical application. The current study was designed to investigate the effects of Chinese medicine Zhoushi Qi...
17.
Bai H, Cao H, Wang D, Chen L, Feng Y, Gao R
Am J Transl Res
. 2021 Sep;
13(8):9241-9247.
PMID: 34540040
Objective: To investigate the feasibility and effectiveness of Xialiqi capsules in rats with nonbacterial prostatitis. Methods: A total of 90 healthy male SD rats, weighing 200-220 g, were randomly divided...
18.
Cao H, Wang D, Gao R, Chen L, Feng Y, Gao D
Aging (Albany NY)
. 2021 Jun;
13(13):17202-17210.
PMID: 34170852
A number of traditional Chinese medicines (TCMs) are widely used in prostate cancer treatment in China. The aim of this study was to test the efficacy of a TCM, Zhoushi...
19.
Cao H, Wang D, Gao R, Chen L, Feng Y
Biochem Biophys Res Commun
. 2021 Jan;
541:56-62.
PMID: 33477033
The present study aims to investigate the roles of U2 Small Nuclear RNA Auxiliary Factor 1 (U2AF1) in the resistance to anti-androgen treatment in prostate cancer and its underlying mechanism....
20.
Cao H, Gao R, Chen L, Feng Y
FEBS Open Bio
. 2020 Jan;
10(4):515-524.
PMID: 31981447
Prostate cancer is the fifth leading cause of cancer-related deaths in males globally. Tripartite Motif Containing 66 (TRIM66) functions as transcriptional repressor and exerts its effect at least partially through...